VPH 2012 Conference of the Virtual Physiological Human Network of Excellence

18 - 20 September 2012, London, UK.
VPH 2012 will be an international conference on computational biomedicine, with a clear focus on the integrative aspects of VPH. Special attention will be given to the 'Digital Patient' as well as 'health forecasts'. VPH 2012 aims at reaching outside of the VPH community to other equally important communities: systems biology and genomics.

VPH 2012 is supported by the European Commission ICT for Health / DG Information Society and Media. The Virtual Physiological Human Network of Excellence is an umbrella project representing the Virtual Physiological Human Initiative set up by the European Commission with a budget of ~ 207 million Euros for the Framework 7 Program.

Four parallel sessions will be held on all days with talks and dedicated poster sessions. Similar to the format of the VPH 2010 - where after the meeting, the best VPH 2010 papers and posters were published in Interface Focus in a special themed issue on the Virtual Physiological Human.

Conference Theme Tracks:

1. Physiome: multiscale modelling of physiology and pathology
(Track chairs: Peter Hunter and S Randall Thomas)

1. Neuromusculoskeletal system
2. Cardiovascular and respiratory systems
3. Internal organs and metabolic modelling
4. Lymphatic and immune systems
5. Neurocognitive modelling
6. ... (any other system)

2. Virtual Physiological Human: infrastructures and technologies for integrative biomedical research
(Track chairs: Rod Hose and Ryutaro Himeno)

1. VPH Infostructure technologies
2. Data and model repositories
3. Multiscale modelling technologies
4. Clinical applications of multiscale modelling
5. Software, platforms and workflows

3. Digital Patient: ICT for integrating data, information, and knowledge in the clinical practice
(Track Chairs: Dipak Kalra and Marco Viceconti)

1. Multiscale visualisation
2. Integrative user interfaces for medical professionals
3. Clinical data fusion and integration
4. Integrative management of clinical information & health informatics
5. Hybrid personalised / population modelling
6. ... (other)

4. System Medicine: bridging Physiome / VPH and Systems Biology
(Track chairs: Adriano Henney and Hans Westerhoff)

1. Tissue modelling: missing link between cells and organs
2. PDE - ODE integration in tissue-cell multiscale models
3. Downward causation

5. Genomics, proteomics and bioinformatics
(Track chairs: Paul Kellam, Ferran Sanz & Nour Shublaq)

1. "Omics" research and its connection to the medical/clinical context. Case studies
2. Whole-genome analysis
3. Disease-based genomic studies
4. Tools and techniques
5. Integrated high-throughput analysis

6. Personal Health Forecasting: next-generation technology for Active and Healthy Ageing
(Track chairs: Filippo Castiglione and Emanuela Merelli)

1. Technology for Active and Healthy Ageing
2. Sensor-model integrated systems
3. Design of Public Health Interventions
4. Data security and storage in clinical applications in this context
5. Case studies - applications in clinical practice
6. ...(other)

7. In-silico clinical trials: integrative information management and integrative modelling to develop and assess medicines, medical devices, tissue engineering, and biotechnology products
(Track Chairs: Norbert Graf and Peter Kohl)

1. Toward deployment: technical assessment and clinical assessment
2. Verification, sensitivity, validation, benchmarking, accuracy, efficacy
3. Cost-benefit analysis & case studies
4. Regulatory aspects

VPH 2012 Scientific Committee

  • Peter Coveney, University College London (Chair), UK
  • Vanessa Diaz, University College London, UK
  • Stephen Emmott, Microsoft Research Laboratory, UK
  • Norbert Graf, University of Saarland, DE
  • Peter Hunter, University of Auckland, NZ
  • Paul Kellam, Wellcome Trust Sanger Institute, UK
  • Peter Kohl, Imperial College London, UK
  • Ferran Sanz, Universitat Pompeu Fabra, ES
  • Jesper Tegner, Karolinska Institutet, SE
  • Marco Viceconti, University of Sheffield, UK

VPH2012 Organisation Office

  • Tara Chapman, Universite Libre de Bruxelles, BE
  • Katherine Fletcher, University of Oxford, UK
  • Miriam Mendes, University College London, UK

For further iformation and registration, please visit:
http://www.vph-noe.eu/vph2012

About the VPH Network of Excellence
The VPH Network of Excellence (VPH NoE) is designed to foster, harmonise and integrate pan-European research in the field of i) patient-specific computer models for personalised and predictive healthcare and ii) ICT-based tools for modelling and simulation of human physiology and disease-related processes.

The main objectives of the VPH Network of Excellence are to support the:

  • Coordination of research portfolios of VPH NoE partners through initiation of Exemplar integrative research projects that encourage inter-institution and interdisciplinary VPH research.
  • Integration of research infrastructures of VPH NoE partners through development of the VPH ToolKit: a shared and mutually accessible source of research equipment, managerial and research infrastructures, facilities and services.
  • Development of a portfolio of interdisciplinary training activities including a formal consultation on, and assessment of, VPH careers.
  • Establishment of a core set of VPH-related dissemination and networking activities which will engage everyone from partners within the VPH NoE/other VPH projects, to national policy makers, to the public at large.
  • Creation of Industrial, Clinical and Scientific Advisory Boards that will jointly guide the direction of the VPH NoE and, through consultation, explore the practical and legal options for real and durable integration within the VPH research community.
  • Implementation of key working groups that will pursue specific issues relating to VPH, notably integrating VPH research worldwide through international physiome initiatives.

Most Popular Now

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

AI Body Composition Measurements can Pre…

Adiposity - or the accumulation of excess fat in the body - is a known driver of cardiometabolic diseases such as heart disease, stroke, type 2 diabetes, and kidney disease...

AI can Strengthen Pandemic Preparedness

How to identify the next dangerous virus before it spreads among people is the central question in a new Comment in The Lancet Infectious Diseases. In it, researchers discuss how...

New AI Tool Scans Social Media for Hidde…

A new artificial intelligence tool can scan social media data to discover adverse events associated with consumer health products, according to a study published September 30th in the open-access journal...

'Future-Guided' AI Improves Se…

In the world around us, many things exist in the context of time: a bird’s path through the sky is understood as different positions over a period of time, and...

Yousif's Story with Sectra and The …

Embarking on healthcare technology career after leaving his home as a refugee during his teenage years, Yousif is passionate about making a difference. He reflects on an apprenticeship in which...

New AI Tools Help Scientists Track How D…

Artificial intelligence (AI) can solve problems at remarkable speed, but it’s the people developing the algorithms who are truly driving discovery. At The University of Texas at Arlington, data scientists...

AI Tool Offers Deep Insight into the Imm…

Researchers explore the human immune system by looking at the active components, namely the various genes and cells involved. But there is a broad range of these, and observations necessarily...

Study Finds One-Year Change on CT Scans …

Researchers at National Jewish Health have shown that subtle increases in lung scarring, detected by an artificial intelligence-based tool on CT scans taken one year apart, are associated with disease...

New Antibiotic Targets IBD - and AI Pred…

Researchers at McMaster University and the Massachusetts Institute of Technology (MIT) have made two scientific breakthroughs at once: they not only discovered a brand-new antibiotic that targets inflammatory bowel diseases...

Highland to Help Companies Seize 'N…

Health tech growth partner Highland has today revealed its new identity - reflecting a sharper focus as it helps health tech companies to find market opportunities, convince target audiences, and...